Department of Dentistry, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
J Periodontol. 2010 Sep;81(9):1250-5. doi: 10.1902/jop.2010.090743.
Cyclosporine, a potent immunosuppressant agent, has significantly reduced the morbidity and mortality rates associated with solid-organ transplantations. The major side effect of this drug in the oral cavity is gingival enlargement. Cyclosporine-induced gingival enlargement was reported by different transplant centers as varying from 7% to 80%. Many factors related to cyclosporine-induced gingival overgrowth have been investigated. However, controversies still exist. This study investigates the effects of cyclosporine on the gingival tissues of liver-transplant pediatric patients, determines the prevalence and severity of gingival overgrowth, and analyzes the relationship between gingival enlargement and possible risk factors.
Twenty-five children aged <4 years old (15 males and 10 females) with end-stage liver disease, and awaiting liver transplantation were selected for this study. During the pretransplant period, baseline data were collected including serum level of cyclosporine and gingival enlargement, plaque, and gingival bleeding indices. After liver transplantation, all subjects received <5 mg/kg cyclosporine as an immunosuppressant agent. The children had the same data collected immediately and 3, 6, and 12 months after liver transplantation.
The results show that the cyclosporine-induced gingival enlargement of these children is not statistically associated with their age, gender, gingival inflammation, or serum level of cyclosporine (P >0.05). The gingival enlargement was found to be significantly related to the plaque index at each time period until 12 months after liver transplantation (P <0.05). An increased tendency of gingival enlargement was found in the immediate post-transplant examination and at 3 months after liver transplantation.
Children administered cyclosporine after liver transplantation show that gingival enlargement is statistically more related to the plaque index than other factors such as age, gender, gingival inflammation, or the serum level of cyclosporine, which suggests that plaque control plays an important role in eliminating gingival enlargement in children who have undergone liver transplantation.
环孢素是一种强效免疫抑制剂,它显著降低了实体器官移植相关的发病率和死亡率。该药物在口腔中的主要副作用是牙龈增生。不同的移植中心报道,环孢素引起的牙龈增生的发生率在 7%到 80%之间不等。许多与环孢素诱导的牙龈过度生长有关的因素已经被研究过。然而,仍然存在争议。本研究调查了环孢素对肝移植儿科患者牙龈组织的影响,确定了牙龈过度生长的患病率和严重程度,并分析了牙龈增大与可能的危险因素之间的关系。
选择 25 名年龄<4 岁(15 名男性和 10 名女性)的终末期肝病和等待肝移植的儿童进行本研究。在移植前期间,收集包括血清中环孢素水平和牙龈增大、菌斑和牙龈出血指数在内的基线数据。肝移植后,所有患儿均接受<5mg/kg 的环孢素作为免疫抑制剂。在肝移植后立即以及 3、6 和 12 个月后,收集所有患儿相同的数据。
结果表明,这些儿童的环孢素诱导的牙龈增大与他们的年龄、性别、牙龈炎症或血清中环孢素水平无统计学关联(P>0.05)。在肝移植后直至 12 个月的每个时间段,牙龈增大均与菌斑指数显著相关(P<0.05)。在肝移植后即刻检查和 3 个月后发现牙龈增大有增加的趋势。
肝移植后接受环孢素治疗的儿童表明,牙龈增大与菌斑指数的关系比年龄、性别、牙龈炎症或血清中环孢素水平等其他因素更为密切,这表明在接受肝移植的儿童中,控制菌斑对于消除牙龈增大起着重要作用。